SIRT1/NFκB pathway mediates anti-inflammatory and anti-apoptotic effects of rosmarinic acid on in a mouse model of nonalcoholic steatohepatitis (NASH)

References

• Gottlieb A, Mosthael W, Sowa JP, et al. Nonalcoholic-fatty-liver-disease and nonalcoholic steatohepatitis: successful development of pharmacological treatment will depend on translational research. Digestion. 2019;100(2):79–85.
   PubMed Web of Science ®Google Scholar
• Henao MJ, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179–185.
   PubMed Web of Science ®Google Scholar
• Wree A, Broderick L, Canbay A, et al. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013;10(11):627–636.
   PubMed Web of Science ®Google Scholar
• Liu W, Baker RD, Bhatia T, et al. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci. 2016;73(10):1969–1987.
   PubMed Web of Science ®Google Scholar
• Noureddin M, Mato JM, Lu SC. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Exp Biol Med (Maywood). 2015;240(6):809–820.
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Q, Liu L, et al. Potential biological effects of (-)-epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease. Mol Nutr Food Res. 2018;62(1):45–47.
   Web of Science ®Google Scholar
• Ibrahim SH, Hirsova P, Gores GJ. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut. 2018;67(5):963–972.
   PubMed Web of Science ®Google Scholar
• Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2014;15(5):7352–7379.
   PubMed Web of Science ®Google Scholar
• de Gregorio E, Colell A, Morales A, et al. Relevance of SIRT1-NF-κB axis as therapeutic target to ameliorate inflammation in liver disease. IJMS. 2020;21(11):3858.
   Web of Science ®Google Scholar
• Tong J, Guo JJ. Key molecular pathways in the progression of non-alcoholic steatohepatitis. Eur Rev Med Pharmacol Sci. 2019;23(19):8515–8522.
   PubMed Web of Science ®Google Scholar
• Ren T, Huang C, Cheng M. Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway. Oxid Med Cell Longev. 2014; 20142014: :1–12.
   Web of Science ®Google Scholar
• Yan T, Huang J, Nisar MF, et al. The beneficial roles of SIRT1 in drug-induced liver injury. Oxid Med Cell Longev. 2019;2019:8506195.
   PubMed Web of Science ®Google Scholar
• Singh V, Ubaid S. Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation. 2020;43(5):1589–1598.
   PubMed Web of Science ®Google Scholar
• Lazaridis N, Tsochatzis E. Current and future treatment options in non-alcoholic steatohepatitis (NASH). Expert Rev Gastroenterol Hepatol. 2017;11(4):357–369.
   PubMed Web of Science ®Google Scholar
• Mushtaq N, Schmatz R, Ahmed M, et al. Protective effect of rosmarinic acid against oxidative stress biomarkers in liver and kidney of strepotozotocin-induced diabetic rats. J Physiol Biochem. 2015;71(4):743–751.
   PubMed Web of Science ®Google Scholar
• Diao J, Wei J, Yan R, et al. Rosmarinic acid suppressed high glucose-induced apoptosis in H9c2 cells by ameliorating the mitochondrial function and activating STAT3. Biochem Biophys Res Commun. 2016;477(4):1024–1030.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen X, Yang L, et al. Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice. Food Funct. 2015;6(3):927–931.
   PubMed Web of Science ®Google Scholar
• Prasannarong M, Saengsirisuwan V, Surapongchai J, et al. Rosmarinic acid improves hypertension and skeletal muscle glucose transport in angiotensin II-treated rats. BMC Complement Altern Med. 2019;19(1):165
   PubMedGoogle Scholar
• Ding Y, Zhang Z, Yue Z, et al. Rosmarinic acid ameliorates H2O2-induced oxidative stress in L02 cells through MAPK and Nrf2 pathways. Rejuvenation Res. 2019;22(4):289–298.
   PubMed Web of Science ®Google Scholar
• Lu C, Zou Y, Liu Y, et al. Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system. Toxicol Appl Pharmacol. 2017;318:69–78.
   PubMed Web of Science ®Google Scholar
• Joardar S, Dewanjee S, Bhowmick S, et al. Rosmarinic acid attenuates cadmium-induced nephrotoxicity via inhibition of oxidative stress, apoptosis, inflammation and fibrosis. IJMS. 2019;20(8):2027.
   Google Scholar
• El-Lakkany NM, El-Maadawy WH, SeifEl-Din SH, et al. Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis. Asian Pac J Trop Med. 2017;10(5):444–453.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ma ZG, Yuan YP, et al. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling. Cell Death Dis. 2018;9(2):102.
   PubMedGoogle Scholar
• Kim M, Yoo G, Randy A, et al. Lemon balm and its constituent, rosmarinic acid, alleviate liver damage in an animal model of nonalcoholic steatohepatitis. Nutrients. 2020;12(4):1166.
   Web of Science ®Google Scholar
• Komeili-Movahhed T, Moslehi A, Golchoob M, et al. Allantoin improves methionine-choline deficient diet-induced nonalcoholic steatohepatitis in mice through involvement in endoplasmic reticulum stress and hepatocytes apoptosis-related genes expressions. Iran J Basic Med Sci. 2019;22:1–9.
   PubMed Web of Science ®Google Scholar
• Nikoukar LR, Nabavizadeh F, Mohamadi SM, et al. Protective effect of ghrelin in a rat model of celiac disease. Acta Physiol Hung. 2014;101(4):438–447.
   PubMedGoogle Scholar
• Kleiner DE, Brunt EM, Van Natta M, Nonalcoholic Steatohepatitis Clinical Research Network, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yan H, Li S, et al. Rosmarinic acid protects rat hippocampal neurons from cerebral ischemia/reperfusion injury via the Akt/JNK3/caspase-3 signaling pathway. Brain Res. 2017;1657:9–15.
   PubMed Web of Science ®Google Scholar
• Zych M, Kaczmarczyk-Sedlak I, Wojnar W, et al. Effect of rosmarinic acid on the serum parameters of glucose and lipid metabolism and oxidative stress in estrogen-deficient rats. Nutrients. 2019;11(2):267.
   PubMed Web of Science ®Google Scholar
• Chen X, Xue H, Fang W, et al. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. Redox Biol. 2019;21:101068
   PubMed Web of Science ®Google Scholar
• Kaminsky-Kolesnikov Y, Rauchbach E, Abu-Halaka D, et al. Cholesterol induces Nrf-2- and HIF-1α-dependent hepatocyte proliferation and liver regeneration to ameliorate bile acid toxicity in mouse models of NASH and fibrosis. Oxid Med Cell Longev. 2020;2020:5393761.
   PubMed Web of Science ®Google Scholar
• Yang J, Fernández-Galilea M, Martínez-Fernández L, et al. Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation. Nutrients. 2019;11(4):872.
   PubMed Web of Science ®Google Scholar
• Ou Q, Weng Y, Wang S, et al. Silybin alleviates hepatic steatosis and fibrosis in NASH mice by inhibiting oxidative stress and involvement with the Nf-κB pathway. Dig Dis Sci. 2018;63(12):3398–3408.
   PubMed Web of Science ®Google Scholar
• Rong H, Liang Y, Niu Y. Rosmarinic acid attenuates β-amyloid-induced oxidative stress via Akt/GSK-3β/Fyn-mediated Nrf2 activation in PC12 cells. Free Radic Biol Med. 2018;120:114–123.
   PubMed Web of Science ®Google Scholar
• Hahn HJ, Kim KB, An IS, et al. Protective effects of rosmarinic acid against hydrogen peroxide-induced cellular senescence and the inflammatory response in normal human dermal fibroblasts. Mol Med Rep. 2017;16(6):9763–9769.
   PubMed Web of Science ®Google Scholar
• Hasanein P, Sharifi M. Effects of rosmarinic acid on acetaminophen-induced hepatotoxicity in male Wistar rats. Pharm Biol. 2017;55(1):1809–1816.
   PubMed Web of Science ®Google Scholar
• Moslehi A, Hamidi-Zad Z. Role of SREBPs in liver diseases: a mini-review. J Clin Transl Hepatol. 2018;6(3):332–338.
   PubMed Web of Science ®Google Scholar
• Hassan NF, Nada SA, Hassan A, et al. Saroglitazar deactivates the hepatic LPS/TLR4 signaling pathway and ameliorates adipocyte dysfunction in rats with high-fat emulsion/LPS model-induced non-alcoholic steatohepatitis. Inflammation. 2019;42(3):1056–1070.
   PubMed Web of Science ®Google Scholar
• Chyau CC, Wang HF, Zhang WJ, et al. Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL/6 mice model via AMPK/Sirt1/SREBP-1c/PPARγ pathway. IJMS. 2020;21(1):360.
   Google Scholar
• Xin FZ, Zhao ZH, Zhang RN, et al. Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα. World J Gastroenterol. 2020;26(18):2203–2220.
   PubMed Web of Science ®Google Scholar
• Iang Z, Yang Z, Zhang H, et al. Genistein activated adenosine 5'-monophosphate-activated protein kinase-sirtuin1/peroxisome proliferator-activated receptor γ coactivator-1α pathway potentially through adiponectin and estrogen receptor β signaling to suppress fat deposition in broiler chickens. Poult Sci. 2021;100(1):246–255.
   PubMed Web of Science ®Google Scholar
• Lee DE, Lee SJ, Kim SJ, et al. Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation. Nutrients. 2019;11(11):2702.
   Web of Science ®Google Scholar
• Sun L, Fan Z, Chen J, et al. Protein inhibitor of activated STAT 4 (PIAS4) regulates pro-inflammatory transcription in hepatocytes by repressing SIRT1. Oncotarget. 2016;7(28):42892–42903.
   PubMedGoogle Scholar
• Chen Z, Yu R, Xiong Y, et al. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):203.
   PubMedGoogle Scholar
• Manco M, Marcellini M, Giannone G, et al. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007;127(6):954–960.
   PubMed Web of Science ®Google Scholar
• Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J. 2004;23(12):2369–2380.
   PubMed Web of Science ®Google Scholar
• Ying HZ, Liu YH, Yu B, et al. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food Chem Toxicol. 2013;52:53–60.
   PubMed Web of Science ®Google Scholar
• Tilg H, Jalan R, Kaser A, et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatology. 2003;38(4):419–425.
   PubMed Web of Science ®Google Scholar
• Huang T, Liu Y, Li H, et al. β-Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline-deficient diet in mice. J Food Biochem. 2020;44:e13408.
   Web of Science ®Google Scholar
• Diao J, Zhao H, You P, et al. Rosmarinic acid ameliorated cardiac dysfunction and mitochondrial injury in diabetic cardiomyopathy mice via activation of the SIRT1/PGC-1α pathway. Biochem Biophys Res Commun. 2021;546:29–34.
   PubMedGoogle Scholar
• Jin BR, Chung KS, Cheon SY, et al. Rosmarinic acid suppresses colonic inflammation in dextran sulphate sodium (DSS)-induced mice via dual inhibition of NF-κB and STAT3 activation. Sci Rep. 2017;7:46252.
   PubMed Web of Science ®Google Scholar
• Kanda T, Matsuoka S, Yamazaki M, et al. Apoptosis and non-alcoholic fatty liver diseases. World J Gastroenterol. 2018; 24(25):2661–2672.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qu X, Gao H, et al. Quercetin attenuates NLRP3 inflammasome activation and apoptosis to protect INH-induced liver injury via regulating SIRT1 pathway. Int Immunopharmacol. 2020;85:106634.
   PubMed Web of Science ®Google Scholar
• Xu RY, Xu XW, Deng YZ, et al. Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway. Biochem Biophys Res Commun. 2019;514(2):401–406.
   PubMed Web of Science ®Google Scholar
• Lin LZ, Chen HH, Lei ZX, et al. Rosmarinic acid protects on rat bone marrow mesenchymal stem cells from hydrogen peroxide-induced apoptosis. J Asian Nat Prod Res. 2018;20(6):570–580.
   PubMed Web of Science ®Google Scholar
• Bahri S, Mies F, Ben Ali R, et al. Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts. PLoS One. 2017;12(9):e0184368.
   PubMed Web of Science ®Google Scholar